JENNIFER BLACK: Open Payments
NPI 1710347943 · TUKWILA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 8 payments from 8 companies in 2025. Trend: 2023 $250 · 2024 $86 · 2025 $240
Food & beverage: $130Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Lundbeck LLC | 1 | $24 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ACADIA Pharmaceuticals Inc | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
Products named: REXULTI, INGREZZA, NUPLAZID, ARISTADA, CAPLYTA, Qelbree.
Industry payments across WA — which companies pay providers there.
